153 related articles for article (PubMed ID: 198423)
1. Adrenal suppression with aminoglutethimide. I. Differential e-fects of aminoglutethimide on glucocorticoid metabolism as a rationale for use of hydrocortisone.
Santen RJ; Wells SA; Runić S; Gupta C; Kendall J; Rudy EB; Samojlik E
J Clin Endocrinol Metab; 1977 Sep; 45(3):469-79. PubMed ID: 198423
[No Abstract] [Full Text] [Related]
2. Successful medical adrenalectomy with amino-glutethimide. Role of altered drug metabolism.
Santen RJ; Lipton A; Kendall J
JAMA; 1974 Dec 23-30; 230(12):1661-5. PubMed ID: 4373589
[No Abstract] [Full Text] [Related]
3. Adrenal suppression with aminoglutethimide. II. Differential effects of aminoglutethimide on plasma androstenedione and estrogen levels.
Samojlik E; Santen RJ; Wells SA
J Clin Endocrinol Metab; 1977 Sep; 45(3):480-7. PubMed ID: 903399
[No Abstract] [Full Text] [Related]
4. Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer.
Santen RJ; Samojlik E; Lipton A; Harvey H; Ruby EB; Wells SA; Kendall J
Cancer; 1977 Jun; 39(6 Suppl):2948-58. PubMed ID: 194681
[TBL] [Abstract][Full Text] [Related]
5. The use of aminoglutethimide in the treatment of patients with metastatic carcinoma of the breast.
Santen RJ; Wells SA
Cancer; 1980 Aug; 46(4 Suppl):1066-74. PubMed ID: 6249490
[No Abstract] [Full Text] [Related]
6. Proceedings: Medical adrenalectomy using aminoglutethimide and dexamethasone in advanced breast cancer.
Lipton A; Santen RJ
Cancer; 1974 Feb; 33(2):503-12. PubMed ID: 4812767
[No Abstract] [Full Text] [Related]
7. Medical adrenalectomy and plasma steroids in advanced breast carcinoma.
Newsome HH; Brown PW; Terz JJ; Lawrence W
Surgery; 1978 Jan; 83(1):83-9. PubMed ID: 619476
[TBL] [Abstract][Full Text] [Related]
8. Endocrine and therapeutic effects of aminoglutethimide in premenopausal patients with breast cancer.
Harris AL; Dowsett M; Jeffcoate SL; McKinna JA; Morgan M; Smith IE
J Clin Endocrinol Metab; 1982 Oct; 55(4):718-22. PubMed ID: 6213633
[TBL] [Abstract][Full Text] [Related]
9. Low-dose aminoglutethimide in treatment of advanced breast cancer.
Stuart-Harris R; Dowsett M; Bozek T; McKinna JA; Gazet JC; Jeffcoate SL; Kurkure A; Carr L; Smith IE
Lancet; 1984 Sep; 2(8403):604-7. PubMed ID: 6147642
[TBL] [Abstract][Full Text] [Related]
10. Endocrine effects of low dose aminoglutethimide with hydrocortisone--an optimal hormone suppressive regimen.
Harris AL; Dowsett M; Cantwell BM; Sainsbury JR; Needham G; Farndon J; Wilson R
Breast Cancer Res Treat; 1986; 7 Suppl():S69-72. PubMed ID: 2943338
[TBL] [Abstract][Full Text] [Related]
11. Potency of the effect of D-stereoisomer of aminoglutethimide on adrenal and extraadrenal steroidogenesis.
Samojlik E; Santen RJ
J Clin Endocrinol Metab; 1980 Sep; 51(3):462-5. PubMed ID: 6447707
[No Abstract] [Full Text] [Related]
12. Aminoglutethimide in tamoxifen-resistant patients: The Melbourne Experience.
Murray RM; Pitt P
Cancer Res; 1982 Aug; 42(8 Suppl):3437s-3441s. PubMed ID: 6211229
[TBL] [Abstract][Full Text] [Related]
13. [The use of aminoglutethimide in the treatment of metastatic breast cancer].
Bellora MG; Ciancio A; Ferrero A; Bergamino T; Zola P; Sismondi P
Minerva Ginecol; 1991 Dec; 43(12):589-93. PubMed ID: 1819778
[TBL] [Abstract][Full Text] [Related]
14. Aminoglutethimide dose and hormone suppression in advanced breast cancer.
Harris AL; Dowsett M; Jeffcoate SL; Smith IE
Eur J Cancer Clin Oncol; 1983 Apr; 19(4):493-8. PubMed ID: 6222901
[TBL] [Abstract][Full Text] [Related]
15. Studies in patients with metastatic breast carcinoma treated with aminoglutethimide for medical adrenalectomy.
Wells SA; Haagensen DE; Misbin R; Lipton A; Smart E; Santen RJ
Surg Forum; 1976; 27(62):101-2. PubMed ID: 1019817
[No Abstract] [Full Text] [Related]
16. Medical and surgical adrenalectomy in patients with advanced breast carcinoma.
Newsome HH; Brown PW; Terz JJ; Lawrence W
Cancer; 1977 Feb; 39(2):542-6. PubMed ID: 837338
[TBL] [Abstract][Full Text] [Related]
17. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
[TBL] [Abstract][Full Text] [Related]
18. Use of aminoglutethimide and hydrocortisone as a "medical adrenalectomy" for treatment of breast carcinoma.
Santen RJ; Lipton A; Harvey H; Wells SA
Prog Clin Cancer; 1982; 8():245-65. PubMed ID: 7156404
[No Abstract] [Full Text] [Related]
19. Adrenal suppression with aminoglutethimide. III. Comparison of plasma delta 4- and delta 5-steroids in postmenopausal women treated for breast carcinoma.
Samojlik E; Santen RJ
J Clin Endocrinol Metab; 1978 Oct; 47(4):717-24. PubMed ID: 162517
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of aminoglutethimide and adrenocorticotropic hormone (ACTH) studied on slices of adrenal glands of the guinea-pig.
Bruni G; Dal Pra P; Segre G
Drugs Exp Clin Res; 1989; 15(4):155-8. PubMed ID: 2550204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
